We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Clavis Pharma and Clovis Oncology Sign $380 Million Partnership

News   Nov 25, 2009

 
Clavis Pharma and Clovis Oncology Sign $380 Million Partnership
 
 
 

RELATED ARTICLES

How to Define Spectrums of Biomarker Outcomes

News

Defining the full spectrum of human disease associated with a biomarker is necessary to advance the biomarker into clinical practice.

READ MORE

Direct Diagnostic Tests for Lyme Disease

News

Diagnostic approaches that have effectively been applied to other emerging infections show promise in directly detecting the bacteria that causes Lyme disease.

READ MORE

First Fully Digital Pathology Lab in UK Improves Cancer Diagnosis

News

A move to digitally scan 100% of slides by Leeds Teaching Hospitals NHS Trust Pathology Lab has been hailed as a crucial step to faster and better diagnosis of cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE